Ranibizumab ophthalmic and Sodium Chloride 0.45% Injection
Determining the interaction of Ranibizumab ophthalmic and Sodium Chloride 0.45% Injection and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ranibizumab ophthalmic
Brand name: Lucentis
Synonyms: Ranibizumab (ophthalmic), Ranibizumab
Generic Name: sodium chloride
Brand name: BD PosiFlush SF, Normal Saline flush, Swabflush, Syrex, Thermoject, Tip-Lok Diluent, Hyper-Sal, Nebusal, Sodium chloride, Inhalation, HyperSal, Nebusal, PulmoSal, Altachlore, Muro 128, Sochlor, Adsorbonac, AK-NaCl
Synonyms: Sodium chloride (flush), Sodium Chloride
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ranibizumab ophthalmic-Sodium Chloride Extracorporeal Solution
- Ranibizumab ophthalmic-Sodium chloride flush
- Ranibizumab ophthalmic-Sodium Chloride Inhalation Solution
- Ranibizumab ophthalmic-Sodium chloride Injection
- Ranibizumab ophthalmic-Sodium Chloride Injection 0.45%
- Ranibizumab ophthalmic-Sodium Chloride Injection 14.6%
- Sodium Chloride 0.45% Injection-Ranitidine
- Sodium Chloride 0.45% Injection-Ranitidine Capsule
- Sodium Chloride 0.45% Injection-Ranitidine Hydrochloride
- Sodium Chloride 0.45% Injection-Ranitidine Injection
- Sodium Chloride 0.45% Injection-Ranitidine Suspension
- Sodium Chloride 0.45% Injection-Ranitidine Syrup